SG10201602144PA - Methods and devices for assessing risk to a putative offspring of developing a condition - Google Patents

Methods and devices for assessing risk to a putative offspring of developing a condition

Info

Publication number
SG10201602144PA
SG10201602144PA SG10201602144PA SG10201602144PA SG10201602144PA SG 10201602144P A SG10201602144P A SG 10201602144PA SG 10201602144P A SG10201602144P A SG 10201602144PA SG 10201602144P A SG10201602144P A SG 10201602144PA SG 10201602144P A SG10201602144P A SG 10201602144PA
Authority
SG
Singapore
Prior art keywords
developing
condition
methods
devices
assessing risk
Prior art date
Application number
SG10201602144PA
Inventor
Piraye Yurttas Beim
Original Assignee
Celmatix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celmatix Inc filed Critical Celmatix Inc
Publication of SG10201602144PA publication Critical patent/SG10201602144PA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
SG10201602144PA 2011-10-03 2012-10-02 Methods and devices for assessing risk to a putative offspring of developing a condition SG10201602144PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161542324P 2011-10-03 2011-10-03

Publications (1)

Publication Number Publication Date
SG10201602144PA true SG10201602144PA (en) 2016-04-28

Family

ID=48044379

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201602144PA SG10201602144PA (en) 2011-10-03 2012-10-02 Methods and devices for assessing risk to a putative offspring of developing a condition
SG11201401222WA SG11201401222WA (en) 2011-10-03 2012-10-02 Methods and devices for assessing risk to a putative offspring of developing a condition

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201401222WA SG11201401222WA (en) 2011-10-03 2012-10-02 Methods and devices for assessing risk to a putative offspring of developing a condition

Country Status (9)

Country Link
US (1) US20130109583A1 (en)
EP (2) EP2764122B1 (en)
JP (1) JP2015527870A (en)
KR (1) KR20140072160A (en)
AU (2) AU2012318734A1 (en)
CA (1) CA2850930A1 (en)
IL (1) IL231861B (en)
SG (2) SG10201602144PA (en)
WO (1) WO2013052505A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150038778A1 (en) * 2012-03-14 2015-02-05 Cewntree Hospitalier Universitaire Pontchaillou Itih5 as a diagnostic marker of uterine development and functional defects
US9177098B2 (en) 2012-10-17 2015-11-03 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US10162800B2 (en) 2012-10-17 2018-12-25 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US9836577B2 (en) 2012-12-14 2017-12-05 Celmatix, Inc. Methods and devices for assessing risk of female infertility
JP6678455B2 (en) 2012-12-21 2020-04-08 エピザイム,インコーポレイティド PRMT5 inhibitors and uses thereof
CN103525921A (en) * 2013-09-27 2014-01-22 西北农林科技大学 Method for breeding kidding traits by utilizing 3-gene pyramiding effect
CA2954895A1 (en) 2014-07-17 2016-01-21 Celmatix Inc. Methods and systems for assessing infertility and related pathologies
WO2016057852A1 (en) * 2014-10-08 2016-04-14 The Broad Institute, Inc. Markers for hematological cancers
WO2016160600A1 (en) * 2015-03-27 2016-10-06 The Johns Hopkins University Method of identifying risk for autism
WO2017087409A1 (en) * 2015-11-18 2017-05-26 Genzyme Corporation Biomarker of polycystic kidney disease and uses thereof
KR101906312B1 (en) * 2016-02-05 2018-10-10 사회복지법인 삼성생명공익재단 Method and system for predicting risk of genetic disease in a putative offspring
EP3482328A4 (en) * 2016-06-03 2020-04-15 Celmatix Inc. Method for assessing fertility based on male and female genetic and phenotypic data
CN105886655A (en) * 2016-06-24 2016-08-24 天津市畜牧兽医研究所 Nucleotide sequence for detecting swine NLRP6 (nod-like receptor family pyrin domain-containing protein 6) and application of nucleotide sequence
AU2018214444A1 (en) * 2017-02-01 2019-09-19 Anlagen Pty Ltd Gamete-secreted growth factors
EP3596100A4 (en) * 2017-03-15 2021-01-13 Juneau Biosciences, L.L.C. Methods of using genetic markers associated with endometriosis
CN108315410B (en) * 2018-04-28 2019-07-12 南京医科大学 DNA methylation marker, primer and its application of one group of assessment early abortion risk
JP2022523564A (en) 2019-03-04 2022-04-25 アイオーカレンツ, インコーポレイテッド Data compression and communication using machine learning
US20220186312A1 (en) * 2020-12-11 2022-06-16 Guzip Biomarkers Corporation Predictive method for assessing the success of embryo implantation
CN113203780B (en) * 2021-05-13 2022-05-31 桂林电子科技大学 Method for detecting GPC3 by using label-free aptamer sensor for non-diagnostic purpose
WO2023159225A2 (en) * 2022-02-18 2023-08-24 Precidiag, Inc. Microbial signatures of autism spectrum disorder
CN114592048A (en) * 2022-03-10 2022-06-07 天津大学温州安全(应急)研究院 Method for predicting coagulation dysfunction of recurrent abortion population in pregnancy

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6100029A (en) 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6028189A (en) 1997-03-20 2000-02-22 University Of Washington Solvent for oligonucleotide synthesis and methods of use
US6566101B1 (en) 1997-06-16 2003-05-20 Anthony P. Shuber Primer extension methods for detecting nucleic acids
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US7013221B1 (en) 1999-07-16 2006-03-14 Rosetta Inpharmatics Llc Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays
KR101054732B1 (en) 2000-07-18 2011-08-05 더 유나이티드 스테이츠 오브 아메리카 애즈 리프리젠티드 바이 더 세크레터리 오브 더 디파트먼트 오브 헬쓰 앤드 휴먼 써비시즈 How to Identify Biological Conditions Based on Hidden Patterns of Biological Data
CA2440754A1 (en) 2001-03-12 2002-09-19 Stephen Quake Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension
US6890763B2 (en) 2001-04-30 2005-05-10 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons
WO2003095978A2 (en) 2002-05-09 2003-11-20 Surromed, Inc. Methods for time-alignment of liquid chromatography-mass spectrometry data
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
US20060195266A1 (en) 2005-02-25 2006-08-31 Yeatman Timothy J Methods for predicting cancer outcome and gene signatures for use therein
US20060234274A1 (en) * 2005-03-29 2006-10-19 Auckland Uniservices Limited Methods of diagnosis
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US7282337B1 (en) 2006-04-14 2007-10-16 Helicos Biosciences Corporation Methods for increasing accuracy of nucleic acid sequencing
EP4134667A1 (en) 2006-12-14 2023-02-15 Life Technologies Corporation Apparatus for measuring analytes using fet arrays
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
WO2008109147A2 (en) * 2007-03-06 2008-09-12 University Of Medicine And Dentistry Of Nj Gstp1 as teratogenic allele for autism and assays and methods based thereon
US20090156412A1 (en) 2007-12-17 2009-06-18 Helicos Biosciences Corporation Surface-capture of target nucleic acids
US8394587B2 (en) * 2008-04-14 2013-03-12 Medical Diagnostic Laboratories, Llc Single nucleotide polymorphisms and use of same predicting male-specific prenatal loss
US20100035252A1 (en) 2008-08-08 2010-02-11 Ion Torrent Systems Incorporated Methods for sequencing individual nucleic acids under tension
US8546128B2 (en) 2008-10-22 2013-10-01 Life Technologies Corporation Fluidics system for sequential delivery of reagents
US20100301398A1 (en) 2009-05-29 2010-12-02 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US8673627B2 (en) 2009-05-29 2014-03-18 Life Technologies Corporation Apparatus and methods for performing electrochemical reactions
US8574835B2 (en) 2009-05-29 2013-11-05 Life Technologies Corporation Scaffolded nucleic acid polymer particles and methods of making and using
WO2010147714A1 (en) * 2009-06-16 2010-12-23 The Trustees Of Columbia University In The City Of New York Autism-associated biomarkers and uses thereof
EP2475786B1 (en) * 2009-09-08 2016-03-30 Laboratory Corporation of America Holdings Compositions and methods for diagnosing autism spectrum disorders
KR20120100938A (en) * 2009-09-23 2012-09-12 셀매틱스, 인크. Methods and devices for assessing infertility and/or egg quality

Also Published As

Publication number Publication date
AU2012318734A1 (en) 2014-04-17
AU2018205068A1 (en) 2018-07-26
WO2013052505A2 (en) 2013-04-11
EP2764122A4 (en) 2015-06-17
EP2764122A2 (en) 2014-08-13
IL231861B (en) 2018-12-31
WO2013052505A3 (en) 2014-05-22
SG11201401222WA (en) 2014-09-26
EP2764122B1 (en) 2017-12-06
CA2850930A1 (en) 2013-04-11
EP3323897A1 (en) 2018-05-23
US20130109583A1 (en) 2013-05-02
JP2015527870A (en) 2015-09-24
KR20140072160A (en) 2014-06-12
IL231861A0 (en) 2014-05-28

Similar Documents

Publication Publication Date Title
IL231861A0 (en) Methods and devices for assessing risk to a putative offspring of developing a condition
GB2508124B (en) Methods and systems to determine a context of a device
EP2788909A4 (en) Medical arrangements and a method for prediction of a value related to a medical condition
GB201406056D0 (en) Assessing social risk due to exposure from linked contacts
EP2787336A4 (en) Stress monitoring device of magneto-elastic and magneto-electric effect type
EP2741678A4 (en) Pupillometric assessment of language comprehension
EP2693373A4 (en) Number of persons measurement device
EP2770823A4 (en) Transgenic animals and methods of use
IL228066A0 (en) Methods of detecting aneuploidy in human embryos
LT3575792T (en) Method of assessing risk of pml
SG2014013387A (en) Devices for testing a battery and methods for testing a battery
GB2489592B (en) Developing device
EP2721404A4 (en) Diagnosis and prognosis of renal injury and renal failure
ZA201207064B (en) Device and method to determine shape of streamer
GB2487662B (en) Developing device
GB201102171D0 (en) Inspection of holes
EP2670436A4 (en) Foxc1 antibodies and methods of their use
EP2677934A4 (en) Methods for monitoring exposure to an event and devices thereof
NO20111156A1 (en) Device for jumping and water activities
PL394036A1 (en) Method for assessing the technical condition of transformers
SI2702430T1 (en) Method for assessing the reliability of a dog-man pair and kit for implementing said method
GB201200649D0 (en) Guitar floating bridge device
TH128207B (en) Methods and equipment for rescuing uncomfortable divers
PL394802A1 (en) Method for automatic calculation of transaction rebates and equipment for using this method